Literature DB >> 726085

Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.

J A Garcia-Rodriguez, F Martin-Luengo.   

Abstract

The activity of amikacin, erythromycin and doxycycline was studied against 18 strains of M. fortuitum and 10 of M. chelonei. The agar dilution technique was used for the evaluation of the minimum inhibitory concentration. Between the three drugs tested, amikacin was the most active, since 66.6% of the M. fortuitum and 80% of M. chelonei strains were inhibited at 12.8 microgram/ml. It is possible that in some circumstances amikacin could be useful in the treatment of infections caused by M. fortuitum or M. chelonei.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 726085     DOI: 10.1016/0041-3879(78)90005-3

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  3 in total

1.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  J M Swenson; R J Wallace; V A Silcox; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

2.  In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.

Authors:  M J Casal; F C Rodriguez; M C Benavente
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

3.  Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Authors:  R J Wallace; J R Dalovisio; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.